Gynecologic oncologist Margaret Liang was named director for the Gynecologic Oncology Fellowship Program at Cedars-Sinai Cancer. She also joined the Division of Gynecologic Oncology, providing care and clinical services for patients within the Department of Obstetrics and Gynecology.
The Diversity in Cancer Research Internship Program, part of the University of Miami Miller School of Medicine, was established to give undergraduate college students from under-represented communities exposure and experience in the hopes of increasing diversity among cancer researchers.
Fern Lazar, managing partner and global health practice leader at FINN Partners, was unanimously elected to the Cancer Research Institute’s board of trustees on July 11.
A $3.9 million grant from FDA will allow researchers with the Center for Tobacco Research at The Ohio State University Comprehensive Cancer Center to evaluate effects of e-cigarette flavors on the smoking behaviors of current adult smokers.
Researchers at Fox Chase Cancer Center and Temple Health were recently awarded a three year, $1.2 million grant to study sulforaphane, a promising cancer preventive agent derived from broccoli and other cruciferous vegetables, for the prevention of malignant mesothelioma.
Cancer Center of Kansas has joined the US Oncology Network, effective July 1, by entering into a managed services partnership. This addition expands the network’s service area into Kansas.
David W. Craig was named professor and inaugural founding chair of Department of Integrative Translational Sciences within Beckman Research Institute of City of Hope. Craig was also named deputy director of translational sciences at Beckman Research Institute and associate director of data science for City of Hope’s NCI-designated comprehensive cancer center in Los Angeles.
On June 22, Sens. Mike Crapo (R-ID), Michael Bennet (D-CO), Ben Cardin (D-MD), and Tim Scott (R-SC) introduced the Medicare Multi-Cancer Early Detection Screening Coverage Act, which would grant Medicare the authority to cover multi-cancer early detection tests once they are approved by FDA.
University of Michigan Rogel Cancer Center has received a grant worth $37 million over five years from NCI. At the same time, the center’s designation as a Comprehensive Cancer Center” was renewed.
The Illinois Health Facilities and Services Review Board approved the University of Chicago Medicine’s plans to build an $815 million, 575,000-square-foot building dedicated to cancer research and care on its medical campus on the city’s South Side.
